Effects of testosterone supplementation on clinical and rehabilitative outcomes in older men undergoing on-pump CABG

Contemporary Clinical Trials

Volumn 33, Issue 4, 2012, Pages 730-738

  Maggio, Marcello ^a   Nicolini, Francesco ^b   Cattabiani, Chiara ^a   Beghi, Cesare ^b   Gherli, Tiziano ^b   Schwartz, Robert S ^c   Valenti, Giorgio ^a   Ceda, Gian Paolo ^a  

^a UNIVERSITY OF PARMA   (Italy)

^b UNIVERSITY OF PARMA MEDICAL SCHOOL   (Italy)

^c UNIVERSITY OF COLORADO   (United States)

Author keywords

CABG; Older men; Physical function; Randomized controlled trial; Testosterone

Indexed keywords

C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TRIACYLGLYCEROL;

AGED; ARTICLE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CONTROLLED CLINICAL TRIAL (TOPIC); CORONARY ARTERY BYPASS GRAFT; DELIRIUM; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; ELECTIVE SURGERY; GRIP STRENGTH; HAND GRIP; HEART FAILURE; HEART REHABILITATION; HEMATOCRIT; HORMONAL THERAPY; HUMAN; INFLAMMATION; INTERNATIONAL PROSTATE SYMPTOM SCORE; MALE; MUSCLE STRENGTH; ON PUMP CORONARY ARTERY BYPASS GRAFT; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PROTEIN BLOOD LEVEL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE (TOPIC); TESTOSTERONE BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL;

AFFECT; AGED; AGED, 80 AND OVER; ANDROGENS; BIOLOGICAL MARKERS; BODY COMPOSITION; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DRUG ADMINISTRATION SCHEDULE; EXERCISE TEST; HUMANS; INFLAMMATION; INJECTIONS, INTRAMUSCULAR; LOWER EXTREMITY; MALE; MUSCLE STRENGTH; MUSCLE WEAKNESS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RECOVERY OF FUNCTION; SINGLE-BLIND METHOD; TESTOSTERONE; TREATMENT OUTCOME;

EID: 84861528503     PISSN: 15517144     EISSN: 15592030     Source Type: Journal    
DOI: 10.1016/j.cct.2012.02.019     Document Type: Article

References (45)

1. Harman S.M., Metter E.J., Tobin J.D., Pearson J., Blackman M.R. Longitudinal effects of aging on serum total and free testosterone levels in healthy men. J Clin Endocrinol Metab 2001, 86:724-731.
2. Spratt D.I., Cox P., Orav J., Moloney J., Bigos T. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab 1993, 76(6):1548-1554.
3. Sharshar T., Bastuji-Garin S., Polito A., De Jonghe B., Stevens R.D., Maxime V., The Groupe de Réflexion et d'Etude des Neuromyopathies En Réanimation Hormonal status in protracted critical illness and in-hospital mortality. Crit Care 2011, 15(1):R47.
4. Spratt D.I., Cox P., Orav J., Moloney J., Bigos T. Reproductive axis suppression in acute illness is related to disease severity. J Clin Endocrinol Metab Jun 1993, 76(6):1548-1554.
5. Spratt D.I., Morton J.R., Nye L., Goodale K. Cardiac surgery as a prospective model for the study of endocrinology in critical illness. Am Coll Chest Physicians Ann Mtng, New Orleans, LA 1994.
6. Murgatroyd P.R., Goldberg G.R., Leahy F.E., Gilsenan M.B., Prentice A.M. Effects of inactivity and diet composition on human energy balance. Int J Obes Relat Metab Disord 1999, 23:1269-1275.
7. Shepard T.Y., Weil K.M., Sharp T.A., Grunwald G.K., Bell M.L., Hill J.O., et al. Occasional physical inactivity combined with a high-fat diet may be important in the development and maintenance of obesity in human subjects. Am J Clin Nutr 2001, 73:703-708.
8. Kortebein P., Ferrando A., Lombeida J., Wolfe R., Ewans W.J. Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA 2007, 297(16):1772-1774.
9. Bergouignan A., Momken I., Schoeller D.A., Normand S., Zahariev A., Lescure B. Regulation of energy balance during long-term physical inactivity induced by bed rest with and without exercise training. J Clin Endocrinol Metab 2010, 95(3):1045-1053. Epub 2010 Jan 8.
10. Valenti G., Bossoni S., Giustina A., Maugeri D., Motta M., Vigna G.B., et al. Consensus document on substitution therapy with testosterone in hypoandrogenic elderly men. Aging Clin Exp Res 2002, 14:439-464.
11. Ferrucci L., Maggio M., Bandinelli S., Basaria S., Lauretani F., Ble A., et al. Low testosterone levels and the risk of anemia in older men and women. Arch Intern Med 2006, 166(13):1380-1388.
12. Basaria S., Dobs A.S. Testosterone making an entry into the cardiometabolic world. Circulation 2007, 116(23):2658-2661.
13. Shores M.M., Matsumoto A.M., Sloan K.L., Kivlahan D.R. Low serum testosterone and mortality in male veterans. Arch Intern Med 2006, 166(15):1660-1665.
14. Malkin C.J., Pugh P.J., Morris P.D., Kerry K.E., Jones R.D., Jones T.H., et al. Testosterone replacement in hypogonadal men with angina improves ischaemic threshold and quality of life. Heart 2004, 90:871-876.
15. Malkin C.J., Pugh P.J., Jones R.D., Kapoor D., Kerry K.E., Channer K.S., et al. The effects of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. J Clin Endocrinol Metab 2004, 89:3313-3318.
16. Krasnoff J.B., Basaria S., Pencina M.J., Jasuja G.K., Vasan R.S., Ulloor J. Free testosterone levels are associated with mobility limitations and physical performance in community-welling men: the Framingham Offspring Study. J Clin Endocrinol Metab 2010, 95(6):2790-2799. Epub 2010 Apr 9.
17. Ottenbacher K.J., Ottenbacher M.E., Ottenbacher A.J., Acha A.A., Ostir G.V. Androgen treatment and muscle strength in elderly men: a meta-analysis. J Am Geriatr Soc 2006, 54(11):1666-1673.
18. Conaway D.G., House J., Bandt K., Hayden L., Borkon A.M., Spertus J.A. The elderly: health status benefits and recovery of function one year after coronary artery bypass surgery. J Am Coll Cardiol 2003, 42:1421-1426.
19. Ferrucci L., Maggio M., Ceda G.P., Beghi C., Valenti G., De Cicco G. Acute postoperative frailty. J Am Coll Surg 2006, 203(1):134-135.
20. Maggio M., Ceda G.P., DeCicco G., Cattadori E., Visioli S., Ablondi F., et al. Acute changes in circulating hormones in older patients with impaired ventricular function undergoing on-pump coronary artery bypass grafting. J Endocrinol Invest 2005, 28:711-719.
21. Maggio M., Lauretani F., Ceda G.P., Bandinelli S., Ling S.M., Metter E.J., et al. Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Arch Intern Med 2007, 167(20):2249-2254.
22. Jankowska E.A., Biel B., Majda J., Szklarska A., Lopuszanska M., Medras M., et al. Anabolic deficiency in men with chronic heart failure: prevalence and detrimental impact on survival. Circulation 2006, 114(17):1829-1837.
23. Spratt D.I., Morton J.R., Kramer R.S., Mayo S.W., Longcope C., Vary C.P.H. Increases in serum estrogen levels during major illness are caused by increased peripheral aromatization. Am J Physiol Endocrinol Metab 2006, 291:E631-E638.
24. Amory J.K., Chansky H.A., Chansky K.L., Camuso M.R., Hoey C.T., Anawalt B.D., et al. Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 2002, 50(10):1698-1701.
25. Srinivas-Shankar U., Roberts S.A., Connolly M.J., O'Connell M.D., Adams J.E., Oldham J.A., et al. Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2010, 95(2):639-650.
26. Caminiti G., Volterrani M., Iellamo F., Marazzi G., Massaro R., Miceli M., et al. Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study. J Am Coll Cardiol 2009, 54(10):919-927.
27. Guralnik J.M., Simonsick E.M., Ferrucci L., Glynn R.J., Berkman L.F., Blazer D.G., et al. A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission. J Gerontol 1994, 49(2):M85-M94.
28. Basaria S., Coviello A.D., Travison T.G., Storer T.W., Farwell W.R., Jette A.M., et al. Adverse events associated with testosterone administration. N Engl J Med 2010, 363:109-122.
29. American Thoracic Society ATS Statement: guidelines for the six minute walk test. Am J Respir Crit Care Med 2002, 166:111-117.
30. Fiorina C., Vizzardi E., Lorusso R., Maggio M., De Cicco G., Nodari S., et al. The six-minute walking test early after cardiac surgery. Reference values and the effects of rehabilitation programme. Eur J Cardiothorac Surg 2007, 32:724-729.
31. Velissaris T., Tang A.T., Murray M., Mehta R.L., Wood P.J., Hett D.A., et al. A prospective randomized study to evaluate stress response during beating-heart and conventional coronary revascularization. Ann Thorac Surg 2004, 78(2):506-512.
32. Maggio M., Ceda G.P., Milaneschi Y., Cattabiani C., Snyder P.J., Ferrucci L. Effects of testosterone treatment on inflammatory markers in older men. Poster P 3-209. Poster Session. The Endocrine Society 93th Annual Meeting 4-7 June 2011, Boston, MA, USA.
33. Shahani S., Braga-Basaria M., Maggio M., Basaria S. Androgens and erythropoiesis: past and present. J Endocrinol Invest Sep 2009, 32(8):704-716. Epub 2009 Apr 7.
34. Calof O., Singh A.B., Lee M.L., Urban R.J., Kenny A.M., Tenover J.L., et al. Adverse events associated with testosterone supplementation of older men: a meta-analysis of randomized, placebo-controlled trials. J Gerontol A Biol Sci Med Sci 2005, 60:1451-1457.
35. Bachman E., Feng R., Travison T., Li M., Olbina G., Ostland T., et al. Testosterone suppresses hepcidin in men: a potential mechanism for testosterone-induced erythrocytosis. J Clin Endocrinol Metab 2010, 95:4743-4747.
36. Tenover J.S. Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab 1992, 75(4):1092-1098.
37. Snyder P.J., Peachev H., Hannoush P., Berlin J.A., Loh L., Lenrow D.A., et al. Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 1999, 84(8):2647-2653.
38. Ly L.P., Jimenez M., Zhuang T.N., Celermajer D.S., Conway A.J., Handlsman D.J. A double-blind, placebo controlled, randomized clinical trial of transdermal dihydrotestosterone gel on muscular strength, mobility, and quality of life in older men with partial androgen. J Clin Endocrinol Metab 2001, 86(9):4078-4088.
39. Ferrando A.A., Sheffield-More M., Yeckel C.W., Gilkinson C., Jiang J., Achacosa A., et al. Testosterone administration to older men improves muscle function: molecular and physiological mechanism. Am J Physiol Endocrinol Metab 2002, 282:E601-E607.
40. Wittert G.A., Chapman I.M., Haren M.T., Mackintosh S., Coates P., Morley J.E. Oral testosterone supplementation increases muscle and decreases fat mass in healthy elderly males with low-normal gonadal status. J Gerontol A Biol Sci Med Sci 2003, 58(7):618-625.
41. Page S.T., Amory J.K., DuBoisBowman F., Bradley A.D., Matsumoto A.M., Bremner W.J., et al. Exogenus Testosterone (T) alone or with Finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. J Clin Endocrinol Metab 2005, 90:1502-1510.
42. Dean J.D., Carnegie C., Rodzvilla J., Smith T. Long-term effects of testim 1% gel in hypogonadal men. Rev Urol 2005, 7(29):87-94.
43. Nair K.S., Rizza A.R., O'Brien P., Dhatariya K., Short K.R., Nehra A., et al. DHEA in elderly women and DHEA or testosterone in elderly men. N Engl J Med 2006, 355(16):1647-1659.
44. Zitzman M. Testosterone deficiency and treatment in older men: definition, treatment and pitfalls. Asian J Androl 2010, 12:623-625.
45. Maggio M., Cattabiani C., Ceda G.P. Hormonal changes during and after cardiac surgery. Cardiothoracic surgery in the elderly 2011, 339-355. Springer, Part 2. M.R. Katlic (Ed.).